Skip to main content

Published locations for PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study

User login

  • Reset your password
  • /content/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /edermatologynews/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /pediatricnews/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /rheumatologynews/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /pediatrics/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /rheumatology/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study
  • /dermatology/article/211026/psoriasis/pasi-75-ixekizumab-approaches-90-pediatric-psoriasis-study